Excel Industries Limited (EXCELINDUS) — Financial Results | 17 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Excel Industries completed a ₹40 crore specialty chemical manufacturing project on schedule, securing ₹25 crore in trade advances.
🔄 What Changed
Revenue reached ₹294 crores (+5% YoY), EBITDA remained stable at ₹42 crores, PAT declined ₹5 crores YoY to ₹29 crores, and a new 1,265 MTPA facility was announced for February 2027 launch.
🔮 What's Next
Targeting higher volumes under the long-term specialty chemical supply agreement and planning product launches in Biocides and Performance Solutions during FY27.
💡 Investor Takeaway
The company maintained profitability despite agrochemical headwinds, with new projects diversifying revenue streams and supporting future growth.

Excel Industries reported Q1 FY27 standalone revenue of ₹294 crores, up 5% YoY, with EBITDA at ₹42 crores and PAT at ₹29 crores. Agrochemical Intermediates faced demand pressure from erratic monsoon conditions, but growth in other segments and contract manufacturing projects offset the decline. PAT fell ₹5 crores YoY due to lower non-operating income. The company completed a ₹40 crore specialty chemical manufacturing project on schedule, securing ₹25 crore in trade advances, and plans to launch a new 1,265 MTPA facility in February 2027. Outlook remains cautious on agrochemical demand but expects non-agro segments to drive performance.

📄 View Original Announcement (PDF)

About Excel Industries Limited (EXCELINDUS)

Chemicals · Agro Chemicals · Listed on NSE

Market Cap: ₹1,217.91 Cr P/E: 17.1 ROE: 4.2% ROCE: 5.5% Div Yield: 1.42%

View full EXCELINDUS stock details →

📡 Get AI alerts when EXCELINDUS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EXCELINDUS — Free

📊 More EXCELINDUS filings

See all EXCELINDUS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when EXCELINDUS files new disclosures

Track EXCELINDUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EXCELINDUS — Free

Free account · 2 AI queries/day